Am J Transplant, Volume 20, Suppl 3 Archives - Page 202 of 223 - ATC Abstracts

2020 American Transplant Congress
Efficacy Of CMV Prophylaxis In Liver Transplant Recipients
S. LeCorchick, T. Tinkham, N. Oliver, L. Lindberg, L. Dong, J. Krong, R. Gilroy
Intermountain Medical Center, Murray, UT
*Purpose: Human cytomegalovirus (CMV) is a ubiquitous beta herpesvirus present in the human population at rates between 30% and 90%. It can be transmitted via…
2020 American Transplant Congress
Cytomegalovirus Preemptive Monitoring Conversion and the Use of a Preemptive Threshold after Solid Organ Transplant
C. Wong, M. Jorgenson, J. Descourouez, C. Saddler, J. Smith, D. Mandelbrot
UWHC, Madison, WI
*Purpose: Cytomegalovirus (CMV) in solid organ transplant (SOT) is associated with negative graft and patient outcomes. Prophylactic agents of choice have substantial cytotoxicity, and patients…
2020 American Transplant Congress
Contrary to Expectation, the Use of Immune Checkpoint Inhibitors is Not Consistently Associated with Early Onset Allograft Rejection in Solid Organ Transplant Recipients
I. Owoyemi¹, C. M. Costello², C. Thongprayoon¹, S. Markovic³, H. Joerg⁴, C. C. Otley⁵, T. Taner⁶, A. R. Mangold², N. Leung¹, S. Herrmann¹, A. Kukla¹
¹Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ²Department of Dermatology, Mayo Clinic, Scottsdale, AZ, ³Division of Medical Oncology, Mayo Clinic, Rochester, MN, ⁴Department of Cardiology, Mayo Clinic, Rochester, MN, ⁵Department of Dermatology, Mayo Clinic, Rochester, MN, ⁶Departments of Surgery & Immunology, Mayo Clinic, Rochester, MN
*Purpose: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but are generally avoided in solid organ transplant recipients (SOTRs) due to concern for allograft rejection…
2020 American Transplant Congress
Supporting “The Decision Project:” Understanding Perceptions of Organ, Eye, and Tissue Donation among Baltimore City Community Members
M. Johnson¹, A. Saha¹, M. Waldram¹, I. Johnson², L. Price², A. Coleman², C. Alexander², D. Segev¹, M. Henderson¹
¹Johns Hopkins, Baltimore, MD, ²The Living Legacy Foundation of Maryland, Halethorpe, MD
*Purpose: Using information provided by the Maryland Motor Vehicle Administration (MVA), it was found that the zip code 21205 in Baltimore City had one of…
2020 American Transplant Congress
Sleep Quality and Psychosocial Factors in Liver Transplant Recipients from an Outpatient Follow-Up Clinic in China
X. Zhu, J. Liu, L. Liu, P. Mao
Transplantation Center, Third Xiangya Hospital, Changsha, China
*Purpose: Sleep disturbance is a severe problem in liver transplant recipients; few studies have confirmed the psychosocial factors associated with sleep quality in patients after…
2020 American Transplant Congress
UNOS Registry Myocarditis Heart Transplantation Outcome
J. P. Li¹, P. Kingsford¹, S. Nuno¹, D. Miklin¹, G. Liu², J. Rahman², K. Pandya², C. Lum³, P. Banankhah², P. Genyk¹, D. Vucicevic⁴, A. Wolfson⁵, R. Chand⁶, K. Yang¹, S. Shah¹, A. Kiankhooy⁷, J. Nattiv², S. Hashmi¹, J. Pizula¹, A. Lee¹, M. Fong², L. Grazette², E. C. DePasquale², A. S. Vaidya²
¹Internal Medicine, Keck Medicine of USC, Los Angeles, CA, ²Cardiology, Keck Medicine of USC, Los Angeles, CA, ³Internal Medicine, The Queen's Medical Center, Honolulu, HI, ⁴Cardiology, Newark Beth-Israel Medical Center, Newark, NJ, ⁵Cardiology, University of Arizona Sarver Heart Center, Tuscon, AZ, ⁶Cardiology, Harbor-UCLA Medical Center, Los Angeles, CA, ⁷Cardiothoracic Surgery, Keck Medicine of USC, Los Angeles, CA
*Purpose: Hospitalized myocarditis patients have a variable course that can require heart transplantation at a rate of about 3-4%. We sought to evaluate the post-transplant…
2020 American Transplant Congress
Recruitment in the Pediatric Heart Transplant TEAMMATE Trial: Observed vs. Expected
K. P. Daly, L. A. Sleeper, L. J. Addonizio, J. C. Alejos, S. Auerbach, M. J. Bock, A. Butto, W. F. Carlo, C. Castleberry, W. J. Dreyer, B. Feingold, J. M. Lamour, E. L. Albers, S. A. Hollander, G. L. Klein, A. Lal, E. Pahl, D. Peng, A. R. Punnoose, J. W. Rossano, T. D. Ryan, J. Su, D. L. Sutcliffe, S. Zangwill, C. S. Almond
TEAMMATE Trial Investigators, Boston, MA
*Purpose: The TEAMMATE (Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients using the MATE Score) Trial is the first multicenter effort to address key scientific…
2020 American Transplant Congress
Donor Lung Travel Distance and Time
C. Lehr¹, M. Skeans², M. Valapour¹, E. Lease³
¹Cleveland Clinic, Cleveland, OH, ²SRTR, Minneapolis, MN, ³University of Washington, Seattle, WA
*Purpose: With the policy change from donation service area (DSA) to 250 nautical miles (NM) as the first unit of US lung allocation, distances between…
2020 American Transplant Congress
Simultaneous Pancreas-Kidney Transplant: – The Effects of Early Steroid Withdrawal, Donor and Recipient Variables on Patient Survival
D. Kloda¹, M. McLeod², M. Romine¹, J. Ladowski², J. Locke¹, C. Young¹
¹Department of Surgery - Division of Transplantation, University of Alabama, Birmingham, AL, ²Department of Surgery, University of Alabama, Birmingham, AL
*Purpose: Simultaneous pancreas-kidney transplantation (SPK) improves survival in type I diabetic patients with end stage renal disease (ESRD). Corticosteroids have traditionally been an integral component…
2020 American Transplant Congress
Characterization of an Integrative Prognostic Score for US Patients Taken from the DART Study
J. Bromberg¹, R. Bloom², P. Sood³
¹University of Maryland, Baltimore, MD, ²Penn Medicine, Philadelphia, PA, ³University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: iBox is a validated cloud-based software as a service (SaaS) algorithm that provides a predictive analysis of the post-transplant patient, quantifying the risk of…